The American Journal of Managed Care > October 2012
The American Journal of Managed Care - October 2012
October 24, 2012 – Elizabeth G. Liles, MD, MSCR; Nancy Perrin, PhD; Ana Gabriela Rosales, MS; Adrianne C. Feldstein, MD, MS; David H. Smith, RPh, MHA, PhD; David M. Mosen, PhD, MPH; and Jennifer L. Schneider, MPH
Fecal immunochemical testing resulted in higher colorectal cancer screening rates than did guaiac fecal occult blood tests, with less dependence on office visits.
October 25, 2012 – Stephen D. Persell, MD, MPH; Janardan Khandekar, MD; Thomas Gavagan, MD; Nancy C. Dolan, MD; Sue Levi, RN, MBA; Darren Kaiser, MS; Elisha M. Friesema, BA, CCRP; Ji Young Lee, MS; and David W. Baker, MD, MPH
We examined the impact of electronic reminders followed by performance reports and financial incentives. Physicians responded more to reports and incentives than to reminders alone.
October 25, 2012 – Arianne M. J. Elissen, MSc; Inge G. P. Duimel-Peeters, PhD; Cor Spreeuwenberg, PhD; Marieke Spreeuwenberg, PhD; and Hubertus J. M. Vrijhoef, PhD
The heterogeneous nature of care processes and patients should be taken into account in both the design and evaluation of disease management programs for diabetes.
October 26, 2012 – Evan S. Fieldston, MD, MBA, MSHP; Richard J. Scarfone, MD; Lisa M. Biggs, MD; Joseph J. Zorc, MD, MSCE; and Susan E. Coffin, MD, MPH
Experience of a pediatric integrated delivery system with the surge from the 2009 H1N1 pandemic is described, emphasizing scale, scope, and flexibility at multiple locations.
October 26, 2012 – David G. Stevenson, PhD; Laura M. Keohane, MS; Susan L. Mitchell, MD, MPH; Barbara J. Zarowitz, PharmD, FCCP, BCPS, CGP, FASCP; and Haiden A. Huskamp, PhD
This study presents data on paid and rejected claims submitted by 1 large long-term care pharmacy over the initial 5 years of Medicare Part D.
October 23, 2012 – Shelley A. Sternberg, MD; Netta Bentur, PhD; Chad Abrams, MA; Tal Spalter, MA; Tomas Karpati, MD; John Lemberger, MA; and Anthony D. Heymann, MB BS
The frailty determination of the Adjusted Clinical Groups“diagnoses based predictive model identified frail elders with moderate success compared with a validated screening questionnaire.
October 23, 2012 – Sylvia J. Hysong, PhD; Kate Simpson, MPH; Kenneth Pietz, PhD; Richard SoRelle, BS; Kristen Broussard Smitham, MBA, MA; and Laura A. Petersen, MD, MPH
Financial incentives may not be strong enough to influence physician goal commitment to guideline-recommended hypertension care when providers attribute performance to forces beyond their control.
October 23, 2012 – Shepherd Roee Singer, MD, MPH; Moshe Hoshen, PhD; Efrat Shadmi, PhD; Morton Leibowitz, MD; Natalie Flaks-Manov, MPH; Haim Bitterman, MD; and Ran D. Balicer, MD, PhD
Integration of written-prescription data into medication adherence measures doubled the number of patients identified as nonadherent and improved prediction of follow-up LDL cholesterol.
October 23, 2012 – Daniel R. Touchette, PharmD, MA; Sapna Rao, BPharm, MS; Purna K. Dhru, PharmD; Weihan Zhao, PhD; Young-Ku Choi, PhD; Inderpal Bhandari, PhD; and Glen D. Stettin, MD
A program identifying and resolving care gaps involving community pharmacists resulted in increased adherence and omission gaps closure and fewer adherence gap reopenings.